Progentec Diagnostics Inc. launched a novel blood test to determine the likelihood that a patient with systemic lupus erythematosus (commonly known as both SLE and lupus) will experience an immunologic disease flare during the coming 12 weeks.
https://www.pharmalive.com/wp-content/uploads/2020/09/Progentec’s-Novel-Blood-Test-Predicts-Lupus-Flares-Up-to-12-Weeks-Before-They-Occur-BioSpace-9-19-20.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-09-21 11:42:372020-09-21 12:48:29Progentec’s Novel Blood Test Predicts Lupus Flares Up to 12 Weeks Before They Occur